Literature DB >> 11577923

Prevention and management of febrile seizures.

R J Baumann1.   

Abstract

Febrile seizures are the most common seizures in childhood and, like all seizures, can be frightening to witness. Therefore, it is not surprising that febrile seizures have been the focus of intense research with an extensive literature describing various preventative measures. In addition, there is also an extensive and sophisticated epidemiological literature delineating the natural history of this disorder in American and British children. For simple febrile seizures, the most common form of this disorder, the epidemiological studies demonstrate a generally benign natural history, making it unlikely that any preventative measure could improve the long term outcome for most children. Children with simple febrile seizures have a slight increased risk of epilepsy, but there are no studies that demonstrate that phenobarbital or other therapy can alter this risk. Daily therapy with phenobarbital or valproic acid can reduce the number of subsequent simple febrile seizures. However, as a recent Practice Parameter from the American Academy of Paediatrics concludes, the risk of adverse effects from daily therapy appears to outweigh the benefit of preventing the short term recurrence of simple febrile seizures. It is possible that in some families, where the occurrence of an additional simple febrile seizure would be particularly distressing, the routine use of oral diazepam during febrile illnesses might be appropriate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577923     DOI: 10.2165/00128072-200103080-00003

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  42 in total

1.  The ineffectiveness of diphenylhydantoin in preventing febrile convulsions in the age of greatest risk, under three years.

Authors:  J C Melchior; F Buchthal; M Lennox-Buchthal
Journal:  Epilepsia       Date:  1971-03       Impact factor: 5.864

2.  Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits.

Authors:  K Chen; T Z Baram; I Soltesz
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

3.  Double-blind, randomized trial of diazepam versus placebo for prevention of recurrence of febrile seizures.

Authors:  E Autret; C Billard; P Bertrand; J Motte; F Pouplard; A P Jonville
Journal:  J Pediatr       Date:  1990-09       Impact factor: 4.406

4.  An open-label study of repeated use of diazepam rectal gel (Diastat) for episodes of acute breakthrough seizures and clusters: safety, efficacy, and tolerance. North American Diastat Group.

Authors:  W G Mitchell; J A Conry; P K Crumrine; R L Kriel; J J Cereghino; L Groves; W E Rosenfeld
Journal:  Epilepsia       Date:  1999-11       Impact factor: 5.864

5.  Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study.

Authors:  E Lahat; M Goldman; J Barr; T Bistritzer; M Berkovitch
Journal:  BMJ       Date:  2000-07-08

6.  Rectal diazepam gel for treatment of acute repetitive seizures. The North American Diastat Study Group.

Authors:  R L Kriel; J C Cloyd; J M Pellock; W G Mitchell; J J Cereghino; N P Rosman
Journal:  Pediatr Neurol       Date:  1999-04       Impact factor: 3.372

7.  Prevention of recurrent febrile convulsions--a randomized therapeutic assay: sodium valproate, phenobarbital and placebo.

Authors:  N Mamelle; J C Mamelle; J C Plasse; M Revol; R Gilly
Journal:  Neuropediatrics       Date:  1984-02       Impact factor: 1.947

8.  Febrile convulsions in a national cohort followed up from birth. II--Medical history and intellectual ability at 5 years of age.

Authors:  C M Verity; N R Butler; J Golding
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-04

9.  Phenobarbital compared with carbamazepine in prevention of recurrent febrile convulsions. A double-blind study.

Authors:  J H Antony; S H Hawke
Journal:  Am J Dis Child       Date:  1983-09

10.  A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures.

Authors:  N P Rosman; T Colton; J Labazzo; P L Gilbert; N B Gardella; E M Kaye; C Van Bennekom; M R Winter
Journal:  N Engl J Med       Date:  1993-07-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.